MarketPR
A GAAP loss of $0.28 per share puts Annexon Biosciences (ANNX) in focus after the company's quarterly print came in $0.04 short of analyst expectations. The implied consensus stood at a $0.24 loss per share.
The miss is clean and attributable, placing the result on the wrong side of the Street by a margin that markets will register.
The earnings print Annexon Biosciences reported GAAP earnings per share of negative $0.28 for the period. Analyst consensus had modeled a loss of $0.24 per share, producing a four-cent shortfall.
That gap lands on the unfavorable side with no ambiguity. The tape's question on any loss-side print is whether the result matched analyst models.
Keep reading